会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • 8-azabicyclo[3.2.1.]oct-2-ene derivatives, their preparation and use
    • 8-氮杂双环[3.2.1]辛-2-烯衍生物,其制备和用途
    • US6100275A
    • 2000-08-08
    • US43294
    • 1998-05-18
    • Peter MoldtJ.o slashed.rgen Scheel-KrugerGunnar M. OlsenElsebet .O slashed.stergaard Nielsen
    • Peter MoldtJ.o slashed.rgen Scheel-KrugerGunnar M. OlsenElsebet .O slashed.stergaard Nielsen
    • A61K31/46A61P3/04A61P25/00A61P25/22A61P25/24A61P25/28C07D451/02C07D451/06A01N43/42C07D401/04C07D451/04
    • C07D451/02C07D451/06
    • A compound having the formula, ##STR1## or any of its enantiomers or any mixture thereof, or a pharmaceutically acceptable salt thereof;whereinR is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl or 2-hydroxyethyl; andR.sup.4 isphenyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF.sub.3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl;3,4-methylenedioxyphenyl;benzyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF.sub.3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl;heteroaryl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF.sub.3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl; ornaphthyl which may be substituted one or more times with substituents selected from the group consisting of halogen, CF.sub.3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino, nitro, heteroaryl and aryl.The compounds possess valuable pharmaceutical properties as monoamine neurotransmitter re-uptake inhibitors.
    • PCT No.PCT / EP96 / 04449 371日期1998年5月18日 102(e)日期1998年5月18日PCT提交1996年10月11日PCT公布。 公开号WO97 / 13770 日期1997年04月17日具有下式的化合物或其任何对映异构体或其任何混合物或其药学上可接受的盐; 其中R是氢,烷基,烯基,炔基,环烷基,环烷基烷基或2-羟乙基; R4是可以被选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂芳基和芳基的取代基取代一次或多次的苯基; 3,4-亚甲二氧基苯基; 可以被选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂芳基和芳基的取代基取代一次或多次的苄基。 可以被选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂芳基和芳基的取代基取代一次或多次的杂芳基; 或萘基,其可以被选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基,硝基,杂芳基和芳基的取代基取代一次或多次。 该化合物具有作为单胺神经递质再摄取抑制剂的有价值的药物性质。
    • 3. 发明授权
    • Fused tropane-derivatives as neurotransmitter reuptake inhibitors
    • 融合的托烷衍生物作为神经递质再摄取抑制剂
    • US5998405A
    • 1999-12-07
    • US51107
    • 1998-06-04
    • J.o slashed.rgen Scheel-KrugerGunnar M. OlsenElsbet .O slashed.stergaard NielsenBjarne Hugo DahlLeif Helth Jensen
    • J.o slashed.rgen Scheel-KrugerGunnar M. OlsenElsbet .O slashed.stergaard NielsenBjarne Hugo DahlLeif Helth Jensen
    • C07D451/02A61K31/00A61K31/439A61K31/46A61P25/04A61P25/18A61P25/22A61P25/24A61P25/28A61P43/00C07D471/08C07D471/18A61K31/55
    • C07D471/18
    • The present invention discloses compounds of the formula, or any of its enantiomers or any mixture thereof, a pharmaceutically acceptable addition salt thereof or the N-oxide thereofwhereinX and Y together forms .dbd.O, .dbd.S, .dbd.NOR.sup.2, .dbd.CR.sup.3 R.sup.4, .dbd.N--CN, .dbd.N--NR.sup.7 R.sup.8, --(CH.sub.2).sub.m --, or--W'--(CH.sub.2).sub.p --W"--, or one of X and Y is hydrogen and the other is --OR.sup.5, --SR.sup.5, or --NR.sup.5 R.sup.6Z is hydrogen, --COOR.sup.9 ;R.sup.3 and R.sup.4 are independently hydrogen, halogen, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, alkoxy, aryl, arylalkyl, or --(CH.sub.2).sub.q --COOR.sup.2 ;R.sup.2, R.sup.5 and R.sup.6 are independently hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, aryl, or arylalkyl, --CO-alkyl, or --SO.sub.2 -alkyl;R.sup.7 and R.sup.8 are independently hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, alkenyl, alkynyl, aryl, or arylalkyl;R.sup.9 is alkyl, alkenyl or alkynyl;R.sup.1 is alkyl, alkenyl, alkynyl, aryl, or arylalkyl;where said aryl groups may be substituted one or more times with substituents selected from the group consisting of halogen, CF.sub.3, CN, alkoxy, cycloalkoxy, alkyl, cycloalkyl, alkenyl, alkynyl, amino and nitro;W' and W" are each independently O or S;n is 1, 2, 3, or 4;m is 2, 3, 4, or 5;p is 1, 2, 3, 4, or 5; andq is 0, 1, 2, 3,or 4.The compounds possess valuable properties as monoamine neurotransmitter, i.e dopamine, and serotonine, reuptake inhibitors.
    • PCT No.PCT / EP96 / 04793 Sec。 371日期:1998年6月4日 102(e)1998年6月4日PCT PCT 1996年11月4日PCT公布。 WO97 / 16451 PCT出版物 日期:1997年5月9日本发明公开了下式的化合物或其任何对映异构体或其任何混合物,其药学上可接受的加成盐或其N-氧化物,其中X和Y一起形成= O,= S,= NOR2, = CR 3 R 4,= N-CN,= N-NR 7 R 8, - (CH 2)m - 或-W' - (CH 2)p -W“ - 或X和Y中的一个是氢,另一个是-OR 5, -SR 5或-NR 5 R 6 Z是氢,-COOR 9; R 3和R 4独立地是氢,卤素,烷基,环烷基,环烷基烷基,烯基,炔基,烷氧基,芳基,芳基烷基或 - (CH 2)q -COOR 2; R2,R5和R6独立地是氢,烷基,环烷基,环烷基烷基,烯基,炔基,芳基或芳基烷基,-CO-烷基或-SO2-烷基; R 7和R 8独立地是氢,烷基,环烷基,环烷基烷基,烯基,炔基,芳基或芳基烷基; R9是烷基,烯基或炔基; R1是烷基,烯基,炔基,芳基或芳基烷基; 其中所述芳基可以被选自卤素,CF 3,CN,烷氧基,环烷氧基,烷基,环烷基,烯基,炔基,氨基和硝基的取代基取代一次或多次。 W'和W“各自独立地为O或S; n为1,2,3或4; m为2,3,4或5; p为1,2,3,4或5; 并且q是0,1,2,3或4.该化合物具有作为单胺神经递质(即多巴胺)和5-羟色胺再摄取抑制剂的有价值的性质。